Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Help & FAQ
Dansk
English
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
Search by expertise, name or affiliation
Ixekizumab for treatment of psoriasis
Beatrice Dyring Andersen
,
Lone Skov
,
Claus Zachariae
Dermatology and Allergy
9
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ixekizumab for treatment of psoriasis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Interleukin-17 (IL-17)
100%
Ixekizumab
100%
Psoriasis Treatment
100%
Clinical Trials
40%
Clinical Practice
20%
Inflammatory Mediators
20%
Recent Advances
20%
Unknown Etiology
20%
Monoclonal Antibody
20%
Psoriasis
20%
Psoriasis Pathogenesis
20%
Chronic Inflammatory Skin Disease
20%
Humanized
20%
IgG4-related Disease (IgG4-RD)
20%
Targeted Therapeutics
20%
Homodimer
20%
Promising Drug
20%
IL-17 Receptor
20%
Biological Rationale
20%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
100%
Ixekizumab
100%
Interleukin 17
80%
Receptor
40%
Clinical Trial
40%
Monoclonal Antibody
20%
Dermatitis
20%
Immunoglobulin G4
20%
Homodimer
20%
Immunology and Microbiology
Ixekizumab
100%
Interleukin 17
80%
Mediator
20%
Monoclonal Antibody
20%
Dermatitis
20%
Immunoglobulin G4
20%